Generic Health wins ‘modest’ cut to Bayer’s $25M damages over Yasmin

Intellectual Property 2018-10-31 11:59 pm By Christine Caulfield | Melbourne

Generic Health has shaved two percent off the $25 million damages awarded pharmaceutical giant Bayer in a patent infringement case over Bayer’s blockbuster oral contraceptive, Yasmin, but the discount is a far cry from the 15 percent it sought on appeal.